In Review: The Health Coverage, Insurance, and Financial Services Committee (HCIFS) held a hearing on a bill requiring coverage of generics and biosimilars. PCMA testified in opposition, citing concerns with generic exclusivity.
Up Next: HCIFS will hold a work session on Wednesday, February 28 at 1:30 PM on a prior authorization bill, a required coverage of insulin with the lowest wholesale acquisition cost bill, and a required coverage of generics and biosimilars bill.
If you have any questions, please contact Sam Hallemeier at shallemeier@pcmanet.org.
